Cosecure Cattle Bolus
Country: Portugal
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
15-03-2012
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
copper 13.4 g
Available from:
Telsol Limited
ATC code:
QA12CX99
Pharmaceutical form:
Continuous-release intraruminal device
Therapeutic group:
Other mineral products, combinations
Therapeutic area:
Cattle
Authorization date:
2010-06-10
Summary of Product characteristics
Revised: January 2011
AN: 01126/2009
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cosecure Cattle Bolus Continuous Release Intraruminal Device (UK, Ireland)
Cosecure
Vet Continuous Release Intraruminal Device (Belgium, Denmark, France,
Luxembourg, Sweden)
Rumifert Continuous Release Intraruminal Device (Germany)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 100g bolus contains the following active substances:
Copper:
13.4g
Cobalt:
0.5g
Selenium, as sodium selenate
0.3g
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Continuous release intraruminal device.
A cylindrical, blue glass continual release intraruminal device approximately 82mm x
24mm and weighing approximately 100g, referred to throughout the text as a bolus.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (over 2 months and weighing at least 100 kg BW)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For prevention and treatment of copper and selenium deficiencies and for
improvement of cobalt supply.
4.3 CONTRAINDICATIONS
Do not administer to non-ruminating calves or to animals weighing less than 100kg
body weight. Do not administer to sheep.
See also Section 4.5, Special Precautions for Use
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The product is not intended for treatment of acute clinical conditions such as
nutritional muscular dystrophy.
Revised: January 2011
AN: 01126/2009
Page 2 of 5
4.5 SPECIAL PRECAUTIONS FOR USE
(I)
SPECIAL PRECAUTIO
Read the complete document
